Author

Karine Bernardeau

Centre National de la Recherche ScientifiqueORCID 0000-0002-6822-7178Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:protein structure· 2 Research Focus:drug response / drug discovery· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

Thomas MauriceiD· 2 shared Agnès Fortun· 1 shared Akandé Rouchidane EyitayoiD· 1 shared Ana Cecília A. RoqueiD· 1 shared Arménio Jorge Moura BarbosaiD· 1 shared Barbara MouratouiD· 1 shared Blandine MoneliD· 1 shared Cécile Dahout-GonzaleziD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

Thomas MauriceORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistrybioRxivPreprintAug 19, 2026

Production of membrane-embedded Bcl-2 proteins - Use of cell-free synthesis in continuous exchange for co-translational insertion of Bcl-2 proteins in lipid bilayer nanodiscs

Joann Kervadec, Akandé Rouchidane Eyitayo, Cécile Dahout-Gonzalez…·Muriel Priault

This paper describes methods to produce membrane-embedded Bcl-2 family proteins using cell-free synthesis in lipid bilayer nanodiscs for structural and functional studies.

DOI 10.64898/2026.08.15.745005

protein structureexperimental assay

𝕏 PostBluesky

BiochemistryInternational Journal of Biological MacromoleculesPeer-reviewedNov 28, 2025

Optimized pipeline for generating highly potent neutralizing Affitins: application to SARS-CoV-2 spike protein

Thomas Maurice, Mélanie Laporte, Nicolas Barquilla…·Frédéric Pecorari

The paper develops a pipeline to generate potent Affitins targeting SARS-CoV-2 spike protein RBD, achieving high neutralization potency with IC50 values as low as 0.8 pM.

DOI 10.1016/j.ijbiomac.2025.149321

protein structureexperimental assay

𝕏 PostBluesky